Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics (2nd Edition): Distribution by Type of Protein degrader (degronimids, PROTACs, SARDs / SERDs, specific BET, DUB and other inhibitors), Therapeutic Areas (Neurological Disorders, Oncological Disorders and Others), Route of administration (Oral, Intravenous and Others), Key Contributing Technologies and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA, and Rest of the World), 2021-2030